For example, the ORs per SD increase of genetically predicted IGF‐1 levels were 1.13 (95% CI 1.03‐1.25; P = .01) for colorectal cancer and 1.10 (95% CI 1.00‐1.21; P = .05) for prostate cancer. Here, IGF1 is linked to prostate cancer.